Detalhe da pesquisa
1.
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Blood
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701426
2.
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Blood
; 141(20): 2493-2507, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302166
3.
A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement.
BMC Neurol
; 23(1): 329, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715128
4.
The impact of ABO blood groups on clinical outcomes and susceptibility to COVID-19: A retrospective study in an unselected population.
Transfusion
; 61(5): 1631-1641, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682150
5.
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
Eur J Haematol
; 106(5): 654-661, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523540
6.
Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway.
Blood
; 119(15): 3523-33, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22354003
7.
The future of anti-CD20 monoclonal antibodies: are we making progress?
Blood
; 117(11): 2993-3001, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21209380
8.
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.
Blood
; 117(17): 4519-29, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21378274
9.
Radioimmunotherapy: strategies for the future in indolent and aggressive lymphoma.
Curr Oncol Rep
; 11(5): 363-70, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19679011
10.
The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab.
Br J Haematol
; 162(6): 842-5, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23772929
11.
Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience.
Hemasphere
; 2(3): e44, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723772
12.
Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin.
Hemasphere
; 6(4): e705, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372792
13.
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.
J Clin Invest
; 119(8): 2143-59, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620786